WHO ICTRP trial
Role of fibrinogen in reducing maternal blood loss during and after delivery of…
CTRI/2024/09/073878 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/09/073878 |
|---|---|
| Public title | Role of fibrinogen in reducing maternal blood loss during and after delivery of baby, in mothers with placenta accreta. |
| Scientific title | Evaluation of the effect of fibrinogen on peripartum hemorrhage in Placenta accreta spectrum (PAS) disorders, a double blind randomized controlled trial. - NIL |
| Primary sponsor | All India Institute Of Medical Sciences New Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3/ Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: O432- Morbidly adherent placenta |
| Interventions | Intervention1: FIBRINOGEN: All participants in the intervention group shall receive single dose of fibrinogen 2 g i.v. in 100 ml saline (taped with opaque covering), as soon as the neonate is delivered and cord is clamped, irrespective of… |
| Registration date | Sep 13, 2024 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: